The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status - a Danish nation-wide cohort study.
作者信息
Aziz Umar
机构信息
Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
出版信息
Acta Oncol. 2025 Jul 2;64:857-858. doi: 10.2340/1651-226X.2025.44082.
Abstract
摘要
相似文献
1
The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status - a Danish nation-wide cohort study.
Acta Oncol. 2025 Jul 2;64:857-858. doi: 10.2340/1651-226X.2025.44082.
2
Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial.
Lancet Haematol. 2025 May 28. doi: 10.1016/S2352-3026(25)00103-6.
4
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Cochrane Database Syst Rev. 2002(2):CD002967. doi: 10.1002/14651858.CD002967.
5
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Cochrane Database Syst Rev. 2003(2):CD002967. doi: 10.1002/14651858.CD002967.
6
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Cochrane Database Syst Rev. 2006 Jan 25(1):CD002967. doi: 10.1002/14651858.CD002967.pub2.
7
The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status - a Danish nation-wide cohort study.
Acta Oncol. 2025 May 7;64:623-629. doi: 10.2340/1651-226X.2025.42422.
9
Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes.
JAMA Ophthalmol. 2024 Jan 1;142(1):53-57. doi: 10.1001/jamaophthalmol.2023.5478.
10
Prevalent Metformin Use in Adults With Diabetes and the Incidence of Long COVID: An EHR-Based Cohort Study From the RECOVER Program.
Diabetes Care. 2024 Nov 1;47(11):1930-1940. doi: 10.2337/DCa24-0032.
本文引用的文献
1
The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status - a Danish nation-wide cohort study.
Acta Oncol. 2025 May 7;64:623-629. doi: 10.2340/1651-226X.2025.42422.
2
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England.
Lancet Diabetes Endocrinol. 2021 May;9(5):293-303. doi: 10.1016/S2213-8587(21)00050-4. Epub 2021 Mar 30.
Zotero 插件